Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Leukemia, Myeloid, Acute 17Leukemia 11Myelodysplastic Syndromes 10Recurrence 8Lymphoma 8Burkitt Lymphoma 8Leukemia, Biphenotypic, Acute 7Multiple Myeloma 6Osteosarcoma 5Lymphoma, Non-Hodgkin 5Sarcoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4Hematologic Neoplasms 4Primary Myelofibrosis 3Neoplasms, Plasma Cell 3Leukemia, Myeloid 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2

Interventions

Rituximab 5Vorinostat 3Lenalidomide 3Irinotecan 3Filgrastim 3Dasatinib 3tanespimycin 2laromustine 2ixabepilone 2fludarabine phosphate 2entinostat 2belinostat 2Radiotherapy 2Paclitaxel 2Etoposide 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2vandetanib 1tirbanibulin 1pyroxamide 1pomalidomide 1ontuxizumab 1obatoclax 1methoxyamine 1imetelstat 1ibrutinib 1etaracizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Intraocular Lymphoma × Methotrexate × Clear all
NCT00221325 2015-02-16

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

University of California, San Francisco

Phase 1 Completed
14 enrolled
Lymphoid

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡